Pag-aaral pangklinika para sa HIV sa Georgia
14 pag-aaral para sa HIV ang naghahanap ng mga kalahok sa mga site sa Georgia.
Mga Lungsod sa Georgia
Opisyal na teksto ng pag-aaral (English)
A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed
- GSK Investigational Site, Decatur
Nagre-recruitPhase 3
Edad 12 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07650916A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)
- Metro Infectious Diseases Consultants L.L.C. ( Site 1509), Decatur
- Mercer university, Department of internal medicine-Clinical Research ( Site 1512), Macon
Nagre-recruitPhase 2/3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 21, 2026 · NCT07266831Implementation Study of Lenacapavir Pre-exposure Prophylaxis for HIV Prevention
- Faebris Medical & Community Education, Atlanta
- Grady Memorial Hospital, Atlanta
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Set 15, 2026 · NCT07473778Screen2Prevent (S2P)
- Emory Atlanta Adolescent Consortium, Atlanta
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 14 hanggang 24 · Lahat ng kasarian · Na-update Ago 17, 2026 · NCT07728123Study of Lenacapavir, Teropavimab, and Zinlirvimab Versus Cabotegravir and Rilpivirine in Virologically Suppressed Adults With HIV-1 on Oral Daily Antiretroviral Therapy
- Atlanta ID Group, PC, Atlanta
- Chatham County Health Department, Savannah
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 14, 2026 · NCT07682961A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)
- GSK Investigational Site, Atlanta
- GSK Investigational Site, Macon
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 23, 2026 · NCT07202546Doravirine (DOR) in Human Immunodeficiency Virus (HIV)-Infected Children Aged 4 Weeks to <12 Years and <45 kg (MK-1439-066)
- Emory Children's Center ( Site 0103), Atlanta
Nagre-recruitPhase 2
4 Weeks – 11 Years · Lahat ng kasarian · Na-update Hul 8, 2026 · NCT04375800Inflammation and Depression in People With HIV
- Grady Memorial Hospital, Atlanta
- Emory University Hospital, Atlanta
Nagre-recruitPhase 2
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update May 28, 2026 · NCT05849038Menopausal HT for Women Living With HIV (HoT)
- The Ponce de Leon Center CRS (5802), Atlanta
Nagre-recruitPhase 4
Edad 40 hanggang 60 · Kababaihan · Na-update May 22, 2026 · NCT06856174Low Dose Naltrexone for Pain in Patients With HIV
- Grady Memorial Hospital, Atlanta
- Emory Midtown Hospital, Atlanta
- Emory University Hospital, Atlanta
Nagre-recruitPhase 4
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Abr 9, 2026 · NCT05537935Baricitinib for Reduction of HIV - CNS
- Grady Memorial Hospital, Atlanta
- Emory University Hospital, Atlanta
Nagre-recruitPhase 2
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Mar 23, 2026 · NCT05452564Clinical Trial to Evaluate the Safety and Immunogenicity of a Priming Regimen of 426c.Mod.Core-C4b Followed by HxB2.WT.Core-C4b Boosts, Both Adjuvanted With 3M-052 AF + Alum, in Adult Participants Without HIV and in Overall Good Health
- Ponce de Leon Center CRS, Atlanta
- The Hope Clinic of the Emory Vaccine Research Center; Emory University, Decatur
Nagre-recruitPhase 1Malugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 55 · Lahat ng kasarian · Na-update Set 25, 2025 · NCT06796686HIV Treatment Adherence Dose Determination Trial
- University of Connecticut Field Site, Atlanta
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 29, 2025 · NCT04577313Pharmacokinetics, Safety, Tolerability of Dolutegravir/Rilpivirine in Pediatrics
- GSK Investigational Site, Atlanta
Nagre-recruitPhase 1/2
Edad 6 hanggang 12 · Lahat ng kasarian · Na-update Set 19, 2024 · NCT05674656Mula sa ClinicalTrials.gov, na-kuha noong Set 30, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.